NEW YORK (GenomeWeb) – Signal Genetics today announced that the College of American Pathologists has awarded accreditations to the firm's Little Rock, Ark.-based laboratory.

"This further demonstrates our company's dedication to providing a quality diagnostic to patients suffering from multiple myeloma, and the physicians who treat them, in order to improve individual care," Signal CEO Sam Riccitelli said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.